Two Canada-based researchers on Wednesday urged governments to delay administering the second dose of Inc’s COVID-19 vaccine, which they said had an efficacy of 92.6% after the first dose, as it was not significantly beneficial in the short term. Danuta Skowronski and Gaston De Serres said their findings were derived …
Read More »